Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Resampling phase III data to assess phase II trial designs and endpoints.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Resampling phase III data to assess phase II trial designs and endpoints.
Resampling phase III data to assess phase II trial designs and endpoints. Clin Cancer Res. 2012 Apr 15; 18(8):2309-15.
View in:
PubMed
subject areas
Benzenesulfonates
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Disease-Free Survival
Female
Humans
Kidney Neoplasms
Male
Niacinamide
Phenylurea Compounds
Pyridines
Randomized Controlled Trials as Topic
Research Design
Treatment Outcome
authors with profiles
Mark Ratain
Theodore Karrison